Acadia Pharmaceuticals (ACAD) Return on Equity [ROE] (2011 - 2026)
Acadia Pharmaceuticals (ACAD) reported Return on Equity [ROE] of 29.79% for Q2 2026, up 1.80 percentage points from 27.99% a year earlier but down 0.56 percentage points from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Acadia Pharmaceuticals posted Return on Equity [ROE] of 39.89%, up 1.00 percentage points from FY2024.
- Return on Equity [ROE] has increased for three consecutive years, with a five-year change of +82.36 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at 38.89% in FY2024 (+53.62 pp), -14.73% in FY2023 (+31.16 pp), -45.89% in FY2022 (-17.14 pp) and -28.75% in FY2021 (+13.72 pp).
- Five-year quarterly Return on Equity [ROE] spans a low of -52.30% in Q4 2022 and a high of 36.46% in Q4 2025.
- Year over year, Return on Equity [ROE] gained in seven of the last eight quarters, with an average year-over-year change of +21.93 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q3 2024 (a gain of 62.75 percentage points); the low point was Q4 2022 (a drop of 22.00 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 30.35% (Q1 2026), 36.46% (Q4 2025) and 30.03% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.97% |
| 10 | Acadia Pharmaceuticals | 3.47 Bn | -4.91 Mn | 279.64 Mn | 29.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.79% |
| Mar 31, 2026 | 30.35% |
| Dec 31, 2025 | 36.46% |
| Sep 30, 2025 | 30.03% |
| Jun 30, 2025 | 27.99% |
| Mar 31, 2025 | 30.56% |
| Dec 31, 2024 | 34.58% |
| Sep 30, 2024 | 23.50% |
| Jun 30, 2024 | 6.24% |
| Mar 31, 2024 | -0.38% |
| Dec 31, 2023 | -15.44% |
| Sep 30, 2023 | -39.25% |
| Jun 30, 2023 | -28.78% |
| Mar 31, 2023 | -37.68% |
| Dec 31, 2022 | -52.30% |
| Sep 30, 2022 | -50.54% |
| Jun 30, 2022 | -46.54% |
| Mar 31, 2022 | -43.53% |
| Dec 31, 2021 | -30.31% |
| Sep 30, 2021 | -33.85% |
API Access
Acadia Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();